What is IGF-1 LR3?
IGF-1 LR3 is a long-acting IGF-1 analogue researched around growth-factor signaling, glucose handling, tissue growth, and high-caution performance contexts.
IGF-1 LR3 dosage snapshot
- Route
- subQ / IM
- Dose range
- 20-50 mcg
- Frequency
- daily
- Duration
- 2-6 weeks
Based on reported research sources; not a dosing instruction.
Potential benefits
- Recovery support
- Tissue repair
- Mobility
- Body composition
- Training adaptation
Safety profile
Unknown risk- Common: Route-specific irritation or tolerability issues may be reported depending on the compound.
- Less common: Headache, fatigue, appetite changes, or GI discomfort can appear in community or study contexts.
- Caution: Risk depends on dose, route, study model, duration, compound quality, and whether human data exists.
Storage and handling
Store according to product-label instructions and batch handling notes. Lyophilized research peptides are commonly kept dry, protected from light, and handled with clean laboratory technique.